The FOSB-IGFBP5-IGF-1 axis: a novel regulatory pathway that suppresses prostate cancer growth

Key Points

• Prostate cancer growth is suppressed through the FOSB-IGFBP5-IGF-1 regulatory pathway, offering new insights.
• Key evidence indicates significant involvement of FOSB and IGFBP5 in modulating IGF-1 levels.
• Analysis reveals that manipulating this pathway may lead to innovative treatments for prostate cancer.
• Highlights the need for further exploration of this pathway to harness its potential for cancer therapies.